Guangxi LiuYao Group Past Earnings Performance
Past criteria checks 5/6
Guangxi LiuYao Group has been growing earnings at an average annual rate of 5%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 8.5% per year. Guangxi LiuYao Group's return on equity is 11.3%, and it has net margins of 4.2%.
Key information
5.0%
Earnings growth rate
4.8%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 8.5% |
| Return on equity | 11.3% |
| Net Margin | 4.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Guangxi LiuYao Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 21,188 | 891 | 1,063 | 38 |
| 30 Jun 24 | 21,110 | 871 | 1,075 | 36 |
| 31 Mar 24 | 21,252 | 889 | 1,056 | 34 |
| 31 Dec 23 | 20,812 | 850 | 1,054 | 35 |
| 30 Sep 23 | 20,447 | 801 | 1,015 | 31 |
| 30 Jun 23 | 20,195 | 775 | 996 | 30 |
| 31 Mar 23 | 19,574 | 742 | 981 | 29 |
| 31 Dec 22 | 19,053 | 702 | 957 | 26 |
| 30 Sep 22 | 18,478 | 641 | 913 | 25 |
| 30 Jun 22 | 18,013 | 603 | 927 | 22 |
| 31 Mar 22 | 17,787 | 577 | 930 | 22 |
| 31 Dec 21 | 17,135 | 564 | 909 | 19 |
| 30 Sep 21 | 16,793 | 602 | 925 | 13 |
| 30 Jun 21 | 16,419 | 646 | 879 | 13 |
| 31 Mar 21 | 16,215 | 734 | 828 | 10 |
| 31 Dec 20 | 15,669 | 712 | 790 | 9 |
| 30 Sep 20 | 15,503 | 746 | 759 | 6 |
| 30 Jun 20 | 15,233 | 724 | 735 | 4 |
| 31 Mar 20 | 15,086 | 710 | 749 | 3 |
| 31 Dec 19 | 14,857 | 685 | 713 | 3 |
| 30 Sep 19 | 14,113 | 685 | 719 | 0 |
| 30 Jun 19 | 13,395 | 629 | 621 | 0 |
| 31 Mar 19 | 12,389 | 575 | 566 | 0 |
| 31 Dec 18 | 11,715 | 528 | 506 | 0 |
| 30 Sep 18 | 11,133 | 503 | 440 | 0 |
| 30 Jun 18 | 10,520 | 465 | 407 | 0 |
| 31 Mar 18 | 9,995 | 431 | 368 | 0 |
| 31 Dec 17 | 9,447 | 401 | 348 | 0 |
| 30 Sep 17 | 8,944 | 381 | 318 | 0 |
| 30 Jun 17 | 8,319 | 365 | 296 | 0 |
| 31 Mar 17 | 7,916 | 341 | 285 | 0 |
| 31 Dec 16 | 7,559 | 321 | 284 | 0 |
| 30 Sep 16 | 7,271 | 280 | 274 | 0 |
| 30 Jun 16 | 7,048 | 255 | 267 | 0 |
| 31 Mar 16 | 6,836 | 231 | 259 | 0 |
| 31 Dec 15 | 6,508 | 208 | 246 | 0 |
| 30 Sep 15 | 6,292 | 201 | 243 | 0 |
| 30 Jun 15 | 6,043 | 184 | 237 | 0 |
| 31 Mar 15 | 5,843 | 173 | 222 | 0 |
| 31 Dec 14 | 5,655 | 170 | 212 | 0 |
| 30 Sep 14 | 5,437 | 163 | 193 | 0 |
| 31 Dec 13 | 4,548 | 149 | 162 | 0 |
Quality Earnings: 603368 has high quality earnings.
Growing Profit Margin: 603368's current net profit margins (4.2%) are higher than last year (3.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603368's earnings have grown by 5% per year over the past 5 years.
Accelerating Growth: 603368's earnings growth over the past year (11.3%) exceeds its 5-year average (5% per year).
Earnings vs Industry: 603368 earnings growth over the past year (11.3%) exceeded the Healthcare industry -5.7%.
Return on Equity
High ROE: 603368's Return on Equity (11.3%) is considered low.